img

Global PD-1 and PD-L1 Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global PD-1 and PD-L1 Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
PD-1 and PD-L1 Inhibitors report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PD-1 and PD-L1 Inhibitors market is projected to reach US$ 145420 million in 2034, increasing from US$ 39550 million in 2022, with the CAGR of 20.2% during the period of 2024 to 2034. Demand from Solid Tumors and Blood-related Tumors are the major drivers for the industry.
North America is the largest consumption place, with a consumption market share nearly 60.40% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 20.66%.Market competition is intense. Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical etc. are the leaders of the industry.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PD-1 and PD-L1 Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Bristol-Myers Squibb
Roche
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Merck KGaA
Segment by Type
PD-1 Inhibitors
PD-L1 Inhibitors

Segment by Application


Solid Tumors
Blood-related Tumors

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the PD-1 and PD-L1 Inhibitors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PD-1 and PD-L1 Inhibitors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PD-1 and PD-L1 Inhibitors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of PD-1 and PD-L1 Inhibitors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PD-1 and PD-L1 Inhibitors introduction, etc. PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of PD-1 and PD-L1 Inhibitors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 PD-1 and PD-L1 Inhibitors Market Overview
1.1 PD-1 and PD-L1 Inhibitors Product Overview
1.2 PD-1 and PD-L1 Inhibitors Market Segment by Type
1.2.1 PD-1 Inhibitors
1.2.2 PD-L1 Inhibitors
1.3 Global PD-1 and PD-L1 Inhibitors Market Size by Type
1.3.1 Global PD-1 and PD-L1 Inhibitors Market Size Overview by Type (2018-2034)
1.3.2 Global PD-1 and PD-L1 Inhibitors Historic Market Size Review by Type (2018-2024)
1.3.3 Global PD-1 and PD-L1 Inhibitors Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.2 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.4 Latin America PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2018-2024)
2 Global PD-1 and PD-L1 Inhibitors Market Competition by Company
2.1 Global Top Players by PD-1 and PD-L1 Inhibitors Sales (2018-2024)
2.2 Global Top Players by PD-1 and PD-L1 Inhibitors Revenue (2018-2024)
2.3 Global Top Players by PD-1 and PD-L1 Inhibitors Price (2018-2024)
2.4 Global Top Manufacturers PD-1 and PD-L1 Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 PD-1 and PD-L1 Inhibitors Market Competitive Situation and Trends
2.5.1 PD-1 and PD-L1 Inhibitors Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by PD-1 and PD-L1 Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into PD-1 and PD-L1 Inhibitors Market
2.8 Key Manufacturers PD-1 and PD-L1 Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PD-1 and PD-L1 Inhibitors Status and Outlook by Region
3.1 Global PD-1 and PD-L1 Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global PD-1 and PD-L1 Inhibitors Historic Market Size by Region
3.2.1 Global PD-1 and PD-L1 Inhibitors Sales in Volume by Region (2018-2024)
3.2.2 Global PD-1 and PD-L1 Inhibitors Sales in Value by Region (2018-2024)
3.2.3 Global PD-1 and PD-L1 Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global PD-1 and PD-L1 Inhibitors Forecasted Market Size by Region
3.3.1 Global PD-1 and PD-L1 Inhibitors Sales in Volume by Region (2024-2034)
3.3.2 Global PD-1 and PD-L1 Inhibitors Sales in Value by Region (2024-2034)
3.3.3 Global PD-1 and PD-L1 Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global PD-1 and PD-L1 Inhibitors by Application
4.1 PD-1 and PD-L1 Inhibitors Market Segment by Application
4.1.1 Solid Tumors
4.1.2 Blood-related Tumors
4.2 Global PD-1 and PD-L1 Inhibitors Market Size by Application
4.2.1 Global PD-1 and PD-L1 Inhibitors Market Size Overview by Application (2018-2034)
4.2.2 Global PD-1 and PD-L1 Inhibitors Historic Market Size Review by Application (2018-2024)
4.2.3 Global PD-1 and PD-L1 Inhibitors Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.2 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.4 Latin America PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2018-2024)
5 North America PD-1 and PD-L1 Inhibitors by Country
5.1 North America PD-1 and PD-L1 Inhibitors Historic Market Size by Country
5.1.1 North America PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America PD-1 and PD-L1 Inhibitors Sales in Volume by Country (2018-2024)
5.1.3 North America PD-1 and PD-L1 Inhibitors Sales in Value by Country (2018-2024)
5.2 North America PD-1 and PD-L1 Inhibitors Forecasted Market Size by Country
5.2.1 North America PD-1 and PD-L1 Inhibitors Sales in Volume by Country (2024-2034)
5.2.2 North America PD-1 and PD-L1 Inhibitors Sales in Value by Country (2024-2034)
6 Europe PD-1 and PD-L1 Inhibitors by Country
6.1 Europe PD-1 and PD-L1 Inhibitors Historic Market Size by Country
6.1.1 Europe PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe PD-1 and PD-L1 Inhibitors Sales in Volume by Country (2018-2024)
6.1.3 Europe PD-1 and PD-L1 Inhibitors Sales in Value by Country (2018-2024)
6.2 Europe PD-1 and PD-L1 Inhibitors Forecasted Market Size by Country
6.2.1 Europe PD-1 and PD-L1 Inhibitors Sales in Volume by Country (2024-2034)
6.2.2 Europe PD-1 and PD-L1 Inhibitors Sales in Value by Country (2024-2034)
7 Asia-Pacific PD-1 and PD-L1 Inhibitors by Region
7.1 Asia-Pacific PD-1 and PD-L1 Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales in Value by Region (2018-2024)
7.2 Asia-Pacific PD-1 and PD-L1 Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific PD-1 and PD-L1 Inhibitors Sales in Value by Region (2024-2034)
8 Latin America PD-1 and PD-L1 Inhibitors by Country
8.1 Latin America PD-1 and PD-L1 Inhibitors Historic Market Size by Country
8.1.1 Latin America PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America PD-1 and PD-L1 Inhibitors Sales in Volume by Country (2018-2024)
8.1.3 Latin America PD-1 and PD-L1 Inhibitors Sales in Value by Country (2018-2024)
8.2 Latin America PD-1 and PD-L1 Inhibitors Forecasted Market Size by Country
8.2.1 Latin America PD-1 and PD-L1 Inhibitors Sales in Volume by Country (2024-2034)
8.2.2 Latin America PD-1 and PD-L1 Inhibitors Sales in Value by Country (2024-2034)
9 Middle East and Africa PD-1 and PD-L1 Inhibitors by Country
9.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales in Value by Country (2018-2024)
9.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck PD-1 and PD-L1 Inhibitors Products Offered
10.1.5 Merck Recent Development
10.2 Bristol-Myers Squibb
10.2.1 Bristol-Myers Squibb Company Information
10.2.2 Bristol-Myers Squibb Introduction and Business Overview
10.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Products Offered
10.2.5 Bristol-Myers Squibb Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Roche PD-1 and PD-L1 Inhibitors Products Offered
10.3.5 Roche Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.4.4 AstraZeneca PD-1 and PD-L1 Inhibitors Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Ono Pharmaceutical
10.5.1 Ono Pharmaceutical Company Information
10.5.2 Ono Pharmaceutical Introduction and Business Overview
10.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Products Offered
10.5.5 Ono Pharmaceutical Recent Development
10.6 Regeneron
10.6.1 Regeneron Company Information
10.6.2 Regeneron Introduction and Business Overview
10.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Regeneron PD-1 and PD-L1 Inhibitors Products Offered
10.6.5 Regeneron Recent Development
10.7 Innovent
10.7.1 Innovent Company Information
10.7.2 Innovent Introduction and Business Overview
10.7.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Innovent PD-1 and PD-L1 Inhibitors Products Offered
10.7.5 Innovent Recent Development
10.8 Hengrui Medicine
10.8.1 Hengrui Medicine Company Information
10.8.2 Hengrui Medicine Introduction and Business Overview
10.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Hengrui Medicine PD-1 and PD-L1 Inhibitors Products Offered
10.8.5 Hengrui Medicine Recent Development
10.9 Junshi Biosciences
10.9.1 Junshi Biosciences Company Information
10.9.2 Junshi Biosciences Introduction and Business Overview
10.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Junshi Biosciences PD-1 and PD-L1 Inhibitors Products Offered
10.9.5 Junshi Biosciences Recent Development
10.10 Merck KGaA
10.10.1 Merck KGaA Company Information
10.10.2 Merck KGaA Introduction and Business Overview
10.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Merck KGaA PD-1 and PD-L1 Inhibitors Products Offered
10.10.5 Merck KGaA Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PD-1 and PD-L1 Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
11.4 PD-1 and PD-L1 Inhibitors Market Dynamics
11.4.1 PD-1 and PD-L1 Inhibitors Industry Trends
11.4.2 PD-1 and PD-L1 Inhibitors Market Drivers
11.4.3 PD-1 and PD-L1 Inhibitors Market Challenges
11.4.4 PD-1 and PD-L1 Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PD-1 and PD-L1 Inhibitors Distributors
12.3 PD-1 and PD-L1 Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of PD-1 Inhibitors
Table 2. Major Company of PD-L1 Inhibitors
Table 3. Global PD-1 and PD-L1 Inhibitors Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global PD-1 and PD-L1 Inhibitors Sales by Type (2018-2024) & (L)
Table 5. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type (2018-2024)
Table 6. Global PD-1 and PD-L1 Inhibitors Sales by Type (2018-2024) & (US& Million)
Table 7. Global PD-1 and PD-L1 Inhibitors Market Share in Value by Type (2018-2024)
Table 8. Global PD-1 and PD-L1 Inhibitors Price by Type (2018-2024) & (USD/ml)
Table 9. Global PD-1 and PD-L1 Inhibitors Sales by Type (2024-2034) & (L)
Table 10. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type (2024-2034)
Table 11. Global PD-1 and PD-L1 Inhibitors Sales by Type (2024-2034) & (US$ Million)
Table 12. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type (2024-2034)
Table 13. Global PD-1 and PD-L1 Inhibitors Price by Type (2024-2034) & (USD/ml)
Table 14. North America PD-1 and PD-L1 Inhibitors Sales by Type (2018-2024) & (L)
Table 15. North America PD-1 and PD-L1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe PD-1 and PD-L1 Inhibitors Sales (L) by Type (2018-2024)
Table 17. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales (L) by Type (2018-2024)
Table 19. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America PD-1 and PD-L1 Inhibitors Sales (L) by Type (2018-2024)
Table 21. Latin America PD-1 and PD-L1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales (L) by Type (2018-2024)
Table 23. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 24. Global PD-1 and PD-L1 Inhibitors Sales by Company (2018-2024) & (L)
Table 25. Global PD-1 and PD-L1 Inhibitors Sales Share by Company (2018-2024)
Table 26. Global PD-1 and PD-L1 Inhibitors Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global PD-1 and PD-L1 Inhibitors Revenue Share by Company (2018-2024)
Table 28. Global Market PD-1 and PD-L1 Inhibitors Price by Company (2018-2024) & (USD/ml)
Table 29. Global PD-1 and PD-L1 Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global PD-1 and PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2022)
Table 32. Date of Key Manufacturers Enter into PD-1 and PD-L1 Inhibitors Market
Table 33. Key Manufacturers PD-1 and PD-L1 Inhibitors Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global PD-1 and PD-L1 Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global PD-1 and PD-L1 Inhibitors Sales by Region (2018-2024) & (L)
Table 37. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 38. Global PD-1 and PD-L1 Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 39. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 40. Global PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2018-2024)
Table 41. Global PD-1 and PD-L1 Inhibitors Sales by Region (2024-2034) & (L)
Table 42. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 43. Global PD-1 and PD-L1 Inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 44. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Region (2024-2034)
Table 45. Global PD-1 and PD-L1 Inhibitors Sales (L), Revenue (US$ Million), Price (USD/ml) and Gross Margin (2024-2034)
Table 46. Global PD-1 and PD-L1 Inhibitors Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) & (L)
Table 48. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application (2018-2024)
Table 49. Global PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 50. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application (2018-2024)
Table 51. Global PD-1 and PD-L1 Inhibitors Price by Application (2018-2024) & (USD/ml)
Table 52. Global PD-1 and PD-L1 Inhibitors Sales by Application (2024-2034) & (L)
Table 53. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application (2024-2034)
Table 54. Global PD-1 and PD-L1 Inhibitors Sales by Application (2024-2034) & (US$ Million)
Table 55. Global PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application (2024-2034)
Table 56. Global PD-1 and PD-L1 Inhibitors Price by Application (2024-2034) & (USD/ml)
Table 57. North America PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) (L)
Table 58. North America PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) (L)
Table 60. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) (L)
Table 62. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) (L)
Table 64. Latin America PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) (L)
Table 66. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 67. North America PD-1 and PD-L1 Inhibitors Sales by Country (2018-2024) & (L)
Table 68. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 69. North America PD-1 and PD-L1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 70. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 71. North America PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (L)
Table 72. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 73. North America PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 74. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 75. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2018-2024) & (L)
Table 76. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 79. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (L)
Table 80. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2018-2024) & (L)
Table 84. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2024-2034) & (L)
Table 88. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2018-2024) & (L)
Table 92. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (L)
Table 96. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2018-2024) & (L)
Table 100. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (L)
Table 104. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2018-2024)
Table 110. Merck PD-1 and PD-L1 Inhibitors Product
Table 111. Merck Recent Development
Table 112. Bristol-Myers Squibb Company Information
Table 113. Bristol-Myers Squibb Introduction and Business Overview
Table 114. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2018-2024)
Table 115. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Roche Company Information
Table 118. Roche Introduction and Business Overview
Table 119. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2018-2024)
Table 120. Roche PD-1 and PD-L1 Inhibitors Product
Table 121. Roche Recent Development
Table 122. AstraZeneca Company Information
Table 123. AstraZeneca Introduction and Business Overview
Table 124. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2018-2024)
Table 125. AstraZeneca PD-1 and PD-L1 Inhibitors Product
Table 126. AstraZeneca Recent Development
Table 127. Ono Pharmaceutical Company Information
Table 128. Ono Pharmaceutical Introduction and Business Overview
Table 129. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2018-2024)
Table 130. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product
Table 131. Ono Pharmaceutical Recent Development
Table 132. Regeneron Company Information
Table 133. Regeneron Introduction and Business Overview
Table 134. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2018-2024)
Table 135. Regeneron PD-1 and PD-L1 Inhibitors Product
Table 136. Regeneron Recent Development
Table 137. Innovent Company Information
Table 138. Innovent Introduction and Business Overview
Table 139. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2018-2024)
Table 140. Innovent PD-1 and PD-L1 Inhibitors Product
Table 141. Innovent Recent Development
Table 142. Hengrui Medicine Company Information
Table 143. Hengrui Medicine Introduction and Business Overview
Table 144. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2018-2024)
Table 145. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product
Table 146. Hengrui Medicine Recent Development
Table 147. Junshi Biosciences Company Information
Table 148. Junshi Biosciences Introduction and Business Overview
Table 149. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2018-2024)
Table 150. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product
Table 151. Junshi Biosciences Recent Development
Table 152. Merck KGaA Company Information
Table 153. Merck KGaA Introduction and Business Overview
Table 154. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2018-2024)
Table 155. Merck KGaA PD-1 and PD-L1 Inhibitors Product
Table 156. Merck KGaA Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. PD-1 and PD-L1 Inhibitors Market Trends
Table 160. PD-1 and PD-L1 Inhibitors Market Drivers
Table 161. PD-1 and PD-L1 Inhibitors Market Challenges
Table 162. PD-1 and PD-L1 Inhibitors Market Restraints
Table 163. PD-1 and PD-L1 Inhibitors Distributors List
Table 164. PD-1 and PD-L1 Inhibitors Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-1 and PD-L1 Inhibitors Product Picture
Figure 2. Global PD-1 and PD-L1 Inhibitors Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global PD-1 and PD-L1 Inhibitors Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global PD-1 and PD-L1 Inhibitors Sales Status and Outlook (2018-2034) & (L)
Figure 5. Product Picture of PD-1 Inhibitors
Figure 6. Global PD-1 Inhibitors Sales YoY Growth (2018-2034) & (L)
Figure 7. Product Picture of PD-L1 Inhibitors
Figure 8. Global PD-L1 Inhibitors Sales YoY Growth (2018-2034) & (L)
Figure 9. Global PD-1 and PD-L1 Inhibitors Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2022 & 2034
Figure 11. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 12. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 13. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 14. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 17. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 18. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-1 and PD-L1 Inhibitors Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-1 and PD-L1 Inhibitors Revenue in 2022
Figure 23. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Solid Tumors
Figure 25. Global Solid Tumors Sales YoY Growth (2018-2034) & (L)
Figure 26. Product Picture of Blood-related Tumors
Figure 27. Global Blood-related Tumors Sales YoY Growth (2018-2034) & (L)
Figure 28. Global PD-1 and PD-L1 Inhibitors Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2022 & 2034
Figure 30. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 31. North America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 32. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 33. Europe PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 36. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 37. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. PD-1 and PD-L1 Inhibitors Manufacturing Cost Structure
Figure 41. PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries